Therapeutic Solutions International Management
Management criteria checks 4/4
Therapeutic Solutions International's El consejero delegado es Tim Dixon , nombrado en Mar 2011, tiene un mandato de 13.08 años. la remuneración anual total es $380.80K , compuesta por 63% salario y 37% primas, incluidas acciones y opciones de la empresa. posee directamente 9.1% de las acciones de la empresa, por valor de $378.03K . La antigüedad media del equipo directivo y del consejo de administración es de 5.2 años y 5.9 años respectivamente.
Key information
Tim Dixon
Chief executive officer
US$380.8k
Total compensation
| CEO salary percentage | 63.0% |
| CEO tenure | 13.1yrs |
| CEO ownership | 8.9% |
| Management average tenure | 5.2yrs |
| Board average tenure | 5.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$3m |
| Jun 30 2023 | n/a | n/a | -US$3m |
| Mar 31 2023 | n/a | n/a | -US$4m |
| Dec 31 2022 | US$381k | US$240k | -US$4m |
| Sep 30 2022 | n/a | n/a | -US$4m |
| Jun 30 2022 | n/a | n/a | -US$4m |
| Mar 31 2022 | n/a | n/a | -US$3m |
| Dec 31 2021 | US$595k | US$227k | -US$3m |
| Sep 30 2021 | n/a | n/a | -US$2m |
| Jun 30 2021 | n/a | n/a | -US$2m |
| Mar 31 2021 | n/a | n/a | -US$2m |
| Dec 31 2020 | US$607k | US$196k | -US$2m |
| Sep 30 2020 | n/a | n/a | -US$2m |
| Jun 30 2020 | n/a | n/a | -US$2m |
| Mar 31 2020 | n/a | n/a | -US$1m |
| Dec 31 2019 | US$286k | US$146k | -US$2m |
| Sep 30 2019 | n/a | n/a | -US$2m |
| Jun 30 2019 | n/a | n/a | -US$2m |
| Mar 31 2019 | n/a | n/a | -US$2m |
| Dec 31 2018 | US$281k | US$174k | -US$2m |
| Sep 30 2018 | n/a | n/a | -US$1m |
| Jun 30 2018 | n/a | n/a | -US$1m |
| Mar 31 2018 | n/a | n/a | -US$1m |
| Dec 31 2017 | US$165k | US$165k | -US$995k |
Compensación vs. Mercado: Tim($USD380.80K) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD740.57K).
Compensación vs. Ingresos: La compensación de Tim ha sido consistente con los resultados de la empresa en el último año.
CEO
Tim Dixon (65 yo)
13.1yrs
Tenure
US$380,800
Compensation
Mr. Timothy George Dixon, also known as Tim, has been the Chairman and President of MolecuVax, Inc. since 2015. Mr. Dixon has been the Chief Executive Officer, President and Chairman of Therapeutic Solutio...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 13.1yrs | US$380.80k | 8.88% $ 295.2k | |
| Chief Scientific Officer | 4.6yrs | US$25.10k | 1.2% $ 40.0k | |
| Chief Medical Officer | 5.8yrs | US$25.10k | no data | |
| Vice President of Business Development | no data | US$25.10k | 0.096% $ 3.2k | |
| Director of Sales | 3.5yrs | no data | no data |
5.2yrs
Average Tenure
54.5yo
Average Age
Equipo directivo experimentado: TSOIEl equipo directivo de la empresa es veterano y experimentado (5 años de antigüedad media).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 13.1yrs | US$380.80k | 8.88% $ 295.2k | |
| Chief Medical Officer | 6.2yrs | US$25.10k | no data | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Director | 8.3yrs | no data | 3.66% $ 121.6k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 5.8yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.5yrs | no data | no data | |
| Chairman of Scientific Advisory Board | 10.8yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.2yrs | no data | no data | |
| Member of Scientific Advisory Board | 8.5yrs | no data | no data | |
| Member of Scientific Advisory Board | 5.9yrs | no data | no data | |
| Member of Scientific Advisory Board | 5.8yrs | no data | no data |
5.9yrs
Average Tenure
60yo
Average Age
Junta con experiencia: La junta directiva de TSOI se considera experimentada (5.6 años de antigüedad promedio).